These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 20969930)
21. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Mereu G; Fà M; Ferraro L; Cagiano R; Antonelli T; Tattoli M; Ghiglieri V; Tanganelli S; Gessa GL; Cuomo V Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4915-20. PubMed ID: 12679519 [TBL] [Abstract][Full Text] [Related]
22. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Ameri A; Wilhelm A; Simmet T Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827 [TBL] [Abstract][Full Text] [Related]
23. Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: Relative preventing effect of PPARγ agonist. Aghaei I; Hajali V; Dehpour A; Haghani M; Sheibani V; Shabani M Brain Res Bull; 2016 Mar; 121():16-25. PubMed ID: 26704786 [TBL] [Abstract][Full Text] [Related]
24. The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum. Pintor A; Tebano MT; Martire A; Grieco R; Galluzzo M; Scattoni ML; Pèzzola A; Coccurello R; Felici F; Cuomo V; Piomelli D; Calamandrei G; Popoli P Neuropharmacology; 2006 Oct; 51(5):1004-12. PubMed ID: 16895732 [TBL] [Abstract][Full Text] [Related]
25. Long-term effects on cardiorespiratory and behavioral responses in male and female rats prenatally exposed to cannabinoid. Patrone LGA; Frias AT; Fantinatti GT; Stabile AM; Klein W; Bícego KC; Gargaglioni LH Am J Physiol Lung Cell Mol Physiol; 2024 Sep; 327(3):L341-L358. PubMed ID: 39012058 [TBL] [Abstract][Full Text] [Related]
27. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. Schneider M; Drews E; Koch M Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450 [TBL] [Abstract][Full Text] [Related]
28. CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones. Haghani M; Shabani M; Javan M; Motamedi F; Janahmadi M Cell Physiol Biochem; 2012; 29(3-4):391-406. PubMed ID: 22508047 [TBL] [Abstract][Full Text] [Related]
29. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. Lévénés C; Daniel H; Soubrié P; Crépel F J Physiol; 1998 Aug; 510 ( Pt 3)(Pt 3):867-79. PubMed ID: 9660899 [TBL] [Abstract][Full Text] [Related]
30. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. Katona I; Rancz EA; Acsady L; Ledent C; Mackie K; Hajos N; Freund TF J Neurosci; 2001 Dec; 21(23):9506-18. PubMed ID: 11717385 [TBL] [Abstract][Full Text] [Related]
31. Activation of cannabinoid CB1 receptors modulates evoked action potentials in rat retinal ganglion cells. Jiang SX; Li Q; Wang XH; Li F; Wang ZF Sheng Li Xue Bao; 2013 Aug; 65(4):355-62. PubMed ID: 23963066 [TBL] [Abstract][Full Text] [Related]
32. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Pistis M; Perra S; Pillolla G; Melis M; Gessa GL; Muntoni AL Neuropharmacology; 2004 Jan; 46(1):115-25. PubMed ID: 14654103 [TBL] [Abstract][Full Text] [Related]
33. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. Hoffman AF; Lupica CR J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707 [TBL] [Abstract][Full Text] [Related]
34. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Takahashi KA; Castillo PE Neuroscience; 2006; 139(3):795-802. PubMed ID: 16527424 [TBL] [Abstract][Full Text] [Related]
35. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels. Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626 [TBL] [Abstract][Full Text] [Related]
36. Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2. Fan SF; Yazulla S Vis Neurosci; 2003; 20(2):177-88. PubMed ID: 12916739 [TBL] [Abstract][Full Text] [Related]
37. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Bambico FR; Nguyen NT; Katz N; Gobbi G Neurobiol Dis; 2010 Mar; 37(3):641-55. PubMed ID: 19969082 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. Hoffman AF; Lupica CR J Neurosci; 2000 Apr; 20(7):2470-9. PubMed ID: 10729327 [TBL] [Abstract][Full Text] [Related]
39. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex. Saez TM; Aronne MP; Caltana L; Brusco AH J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778 [TBL] [Abstract][Full Text] [Related]
40. Dendritic calcium spikes are tunable triggers of cannabinoid release and short-term synaptic plasticity in cerebellar Purkinje neurons. Rancz EA; Häusser M J Neurosci; 2006 May; 26(20):5428-37. PubMed ID: 16707795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]